News

Filter Results

Press Releases and Statements

CHPA’s President and CEO, Scott Melville, released a statement in response to the introduction of the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

May 27, 2022

CHPA’s President & CEO, Scott Melville, released a statement in response to the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

May 18, 2022

CHPA has issued a statement in response to a recent, observational NSAID study published in the journal Science Translational Medicine.

May 17, 2022

Publications

On this episode of CHPA Chat, we're talking about the explosion in digital health. Not just the watch you may be wearing, but technology that could enable healthcare, and very importantly self-care. Today, we're talking about digital health, what it means for the industry, and what the future holds for this rapidly growing sector.

May 16, 2022

In today's episode, we're discussing a topic that doesn't often get the attention it needs — sexual health. Join Anita Brikman and Bruce Weiss as they explore the state of sexual health in the US today and the role that OTC sexual health products play.

May 2, 2022

On this episode of CHPA Chat, we're talking about the booming business of dietary supplements, especially as a result of the COVID-19 pandemic. But class action lawsuits are also on the rise. In today's episode, we're discussing this real risk to companies and what they can do to get ready.

Apr 18, 2022

Newsletters

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

May 25, 2022

CHPA's "Spotlight" series highlights different Associate member companies in various categories on a rotating basis. This week spotlights Fresh Branding Group, Grey Group, Lamer Advertising, Let There Be, and Reingold. 

May 24, 2022

Filter Results